Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?

Lancet Oncol. 2017 Jun;18(6):706-707. doi: 10.1016/S1470-2045(17)30330-3.

Authors

Winette T A van der Graaf¹, Robin L Jones²

Affiliations

¹ Division of Clinical Studies, Institute of Cancer Research and Sarcoma Unit of the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
² Division of Clinical Studies, Institute of Cancer Research and Sarcoma Unit of the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. Electronic address: [email protected].

PMID: 28593841
DOI: 10.1016/S1470-2045(17)30330-3

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy*
Sarcoma*
Soft Tissue Neoplasms